Legend Biotech Corporation - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Legend Biotech Corporation - ADR
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
/ 
Frequently asked questions
To buy Legend Biotech Corporation - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Legend Biotech Corporation - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Legend Biotech Corporation - ADR is LEGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Legend Biotech Corporation - ADR has its primary listing on NASDAQ. You can trade Legend Biotech Corporation - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Legend Biotech Corporation - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Legend Biotech Corporation - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Legend Biotech Corporation - ADR.